Parental Acceptance of Fetal Tissue Donation.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE
    • Publication Information:
      Original Publication: Chicago, IL : American Medical Association, [2018]-
    • Subject Terms:
      Tissue and Organ Procurement*/statistics & numerical data; Humans ; Female ; Adult ; Pregnancy ; Netherlands ; Parents/psychology ; Cohort Studies ; Fetus ; Abortion, Induced/statistics & numerical data ; Abortion, Induced/psychology ; Decision Making ; Male
    • Abstract:
      Importance: Human fetal tissue is essential for biomedical research, providing unparalleled insights into human development and disease.
      Objective: To assess changes in parental decisions to donate fetal tissue following termination of pregnancy after the introduction of the Dutch Fetal Biobank (DFB) and to identify factors associated with consent to donate.
      Design, Setting, and Participants: This cohort study collected data from all individuals assigned female at birth (hereafter referred to as participants) who underwent a termination of pregnancy at the Amsterdam University Medical Center from January 1, 2008, to December 31, 2022. No exclusion criteria were applied.
      Exposure: Introduction of the DFB on September 1, 2017, which offers the option to donate fetal tissue after pregnancy termination.
      Main Outcome and Measure: Rates of fetal tissue donation before and after DFB introduction and associations between patient characteristics (maternal age, race and ethnicity, socioeconomic status, gestational age, and reason for termination) and consent to donation were assessed using multivariable binary logistic regression modeling.
      Results: Of a total of 1272 participants (mean [SD] age, 33.0 [5.4] years), 576 (45.3%) were nulliparous. The mean (SD) gestational age at termination was 18 weeks 3 days (26 days), and reasons for termination were primarily because of structural defects (567 participants [44.6%]), with only a small portion (58 participants [4.6%]) terminating for social reasons (eg, unwanted or unplanned pregnancy). Fetal tissue donations increased from 1.2% (8 donations among 663 terminations) before the DFB introduction to 21.7% (132 donations among 609 terminations) after its introduction. This rise was primarily due to a shift from collective cremation to donation, while individual cremation or burial rates remained stable. The consent rate was 30.3% (132 of 436) for participants informed about the donation option. No significant demographic differences were found between participants who consented and those who did not, except for gestational age; consent rates decreased with advanced gestational age (odds ratio per week, 0.88; 95% CI, 0.83-0.94). Higher consent rates were observed for terminations due to social reasons (odds ratio, 3.56; 95% CI, 1.40-9.10).
      Conclusions and Relevance: These findings suggest that a substantial proportion of individuals may be willing to donate fetal tissue for biomedical research after pregnancy termination. Integrating donation options in posttermination counseling respects patient autonomy and could ethically increase tissue availability for research. Expanding biobanks and fostering international collaboration is crucial for standardizing practices and ensuring equitable research benefits.
    • References:
      Obstet Gynecol. 2021 Nov 1;138(5):755-761. (PMID: 34619743)
      Prenat Diagn. 2007 Aug;27(8):709-16. (PMID: 17533631)
      Br J Radiol. 2023 Apr 1;96(1145):20220744. (PMID: 36802835)
      Bioethics. 2010 Jul;24(6):309-22. (PMID: 19222447)
      Am J Obstet Gynecol. 2009 Aug;201(2):160.e1-7. (PMID: 19560116)
      iScience. 2024 May 07;27(6):109909. (PMID: 38812539)
      Am J Obstet Gynecol. 2010 Apr;202(4):e6; author reply e6-7. (PMID: 20350638)
      Nature. 2015 Dec 10;528(7581):178-81. (PMID: 26659164)
      Dev Cell. 2023 Dec 18;58(24):2826-2835. (PMID: 38113849)
      Arch Intern Med. 2002 Jul 8;162(13):1457-62. (PMID: 12090881)
      PLoS Med. 2008 Sep 16;5(9):e192. (PMID: 18798689)
      Soc Sci Med. 2009 Feb;68(4):781-9. (PMID: 19095337)
      J Med Ethics. 1994 Mar;20(1):36-40. (PMID: 8035438)
      Eur J Hum Genet. 2013 Jan;21(1):14-20. (PMID: 22669414)
      Scand J Public Health. 2004;32(3):224-9. (PMID: 15204184)
      Laryngoscope. 2024 Oct;134(10):4389-4395. (PMID: 38676421)
      Croat Med J. 2011 Jun;52(3):262-79. (PMID: 21674823)
      Acta Obstet Gynecol Scand. 2024 Sep;103(9):1868-1876. (PMID: 38978342)
      Stem Cell Reports. 2023 Dec 12;18(12):2300-2312. (PMID: 37977142)
    • Publication Date:
      Date Created: 20241108 Date Completed: 20241108 Latest Revision: 20241116
    • Publication Date:
      20241116
    • Accession Number:
      PMC11549655
    • Accession Number:
      10.1001/jamanetworkopen.2024.44238
    • Accession Number:
      39514224